Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Stealth Bio’s SBT-272 Shows Encouraging Action In Huntington’s Disease Animal Model
Stealth BioTherapeutics Corp (NASDAQ: MITO) announced the presentation of
Stealth BioTherapeutics Highlights New SBT-272 Data, Trial Initiation
Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction,
Stealth Biotherapeutics Reports New Data On Complement Gene Expression, Cell Survival In Dry Age-Related Macular Degeneration To Be Presented At Association for Research in Vision and Ophthalmology May 4 5-7 p.m. EDT
Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction,
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Allarity Therapeutics (NASDAQ:ALLR) stock rose 25.3% to $2.84 during Monday's after-market session. The market value of their outstanding shares is at $22.9 million.
The Daily Biotech Pulse: AbbVie’s Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours: